ArticleScientific reports2024

The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy.

Edy Kornelius et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.